GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. How Guardant Health is Supporting Cancer Care During the Pandemic. Announces Proposed Convertible Senior Notes Offering Why Guardant Health Stock Is Jumping Today Investors reacted positively to the company's clinical update for its Guardant360 liquid biopsy. GlobeNewswire. Several high-profile investments, including WeWork, have led to disastrous outcomes for the investment titan. The yearly more of GH stock is set at 24.11% by far, with shares price recording returns by 12.68% in the latest quarter. There are several factors that may be causing the movement in the stock. Press Releases; Resources and Media Assets; Contacts; Careers. Year-to-date, Guardant Health Inc. (NASDAQ:GH) stock gained 9.5% and on July … He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. Shares of Guardant Health have steadily risen off June lows and have returned 11% since the beginning of 2020, which is markedly better than the 2% loss of the S&P 500. Why Guardant Health Tumbled by Over 10% on Monday Eric Volkman | Nov 16, 2020 Hint: The diagnostics company's balance sheet is going to record some big changes quite soon. A simple blood draw helps cancer patients get the right drug. Better Coronavirus Stock: Quidel or Guardant Health? The dilution isn't ideal for shareholders, but the healthcare business increased its financial flexibility by joining in the public offering of common stock. Over the last 12 months, GH stock dropped by -14.05%. Guardant Health, Inc. GH 126.09 1.94 (1.56%). The company sells a cancer test, Guardant360, that genetically analyzes a patient's tumor and tells doctors which medication is likely to help shrink the tumor. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Guardant Health Inc. [NASDAQ: GH] stock went on a downward path that fall over -3.40% on Wednesday, amounting to a one-week price decrease of less than -5.41%. Guardant Health, Inc. (GH) is catching the eye of the trading community. Shares of Guardant Health ( NASDAQ:GH) were slipping Friday after investors noticed that one of the company's independent directors sold off some shares. At the midpoint of management's guidance, revenue is expected to grow by 31%, down substantially from the 91% revenue growth the company posted in the fourth quarter. Image source: Getty Images. Jul-05-20 07:07AM : Buying These 3 Stocks Could Make You Crazy Rich. Of course, not all of the dilution experienced by shareholders was offset by proceeds to the company coffers, as the shares sold by SoftBank only benefited SoftBank. Returns as of 12/15/2020. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Is Guardant Health worth watching? The one-year Guardant Health Inc. stock forecast points to a potential upside of 29.87. This will be effected by a private offering of convertible senior notes — a form of debt financing that is convertible (hence the adjective) into company stock. Stock Advisor launched in February of 2002. Why is Guardant Health stock dropping? GH saw -25.86% change opposing the low price in … Guardant Health raised gross proceeds of $362 million from its portion of the offering, which is an impressive haul. Over the past six months, GH shares showcased -0.64% decrease. Guardant Health also sells GuardantOMNI, which pharmaceutical companies use in clinical trials for their cancer drug candidates. Motley Fool. The stock is worth watching. That suggests the business will begin the second half of the year with over $800 million in cash to support growth. Returns as of 12/15/2020. See you at the top! Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Maxx has been a contributor to Fool.com since 2013. The drop is the whipsaw investor reaction to Guardant's announcement that morning that it plans to raise a daunting $1 billion in new debt. A high-level overview of Guardant Health, Inc. (GH) stock. Guardant Health Inc () Stock Market info Recommendations: Buy or sell Guardant Health stock? Even if the COVID-19 coronavirus outbreak gets worse, people are still going to get cancer and need to figure out which treatments are required. Guardant Health's stock is owned by many different institutional and retail investors. When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. SoftBank Vision Fund shed 4.9 million shares of high-flying Guardant Health Inc. as the fund’s other investments faced valuation and regulatory turmoil. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Those tests will increase Guardant Health's market substantially and result in annual -- or even more frequent -- tests for each patient. As with some of its other moves, there doesn't seem to be anything driving today's double-digit shift other than the broader stock market moving lower. Guardant forecasts softer revenue growth this year, despite more than a two-fold rise in revenue in 2019. 10 stocks we like better than Guardant Health. Why Is Everyone Talking About Guardant Health Stock? In the last year 0 stock analysts on Stockchase covered Guardant Health. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Let's conquer your financial goals together...faster. There was little mystery as to why this occurred. Find the latest Guardant Health, Inc. (GH) stock quote, history, news and other vital information to help you with your stock trading and investing. 08:05AM : Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic . Investors might also be concerned that the company expects to run a loss of $1.65 to $1.70 per share this year, larger than last year's $0.84 per share. Let's conquer your financial goals together...faster. Since closing at $84.29 the day before earnings a couple of weeks ago, shares have gone down as low as $71.52, as high as $87, back down to $73.15, and back up to $84.29 before falling over the last two trading days. finance.yahoo.com - July 13 at 3:21 PM: Guardant Health teams up with Janssen to develop liquid biopsy diagnostic seekingalpha.com - July 8 at 1:48 PM: Here's Why Guardant Health Dropped 10.2% in June www.nasdaq.com - July 8 at 1:48 PM: Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology … Better Coronavirus Stock: Quidel or Guardant Health? Market data powered by FactSet and Web Financial Group. Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. Stock Advisor launched in February of 2002. So what. Jul-02-20 09:03AM : 10 Stocks to Invest in the Health Care Revolution. Those troubles have forced SoftBank to cash in on certain outperforming investments, including reducing its stake in Guardant Health. Guardant Health's product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and early detection. Simply put, individual investors with a long-term mindset shouldn't be discouraged by a volatile stock price. Here's Why Guardant Health Dropped 10.2% in June - www.fool.com. Guardant Health Inc. (NASDAQ:GH) is a biotechnology company. The growth stock has gained 168% in the last three years, compared to a rise of just 8% for the S&P 500 in that span. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Motley Fool. Market data powered by FactSet and Web Financial Group. Here's Why Guardant Health Dropped 10.2% in June. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. However, the business sold only 4.3 million shares, whereas SoftBank Investment Advisers sold the remaining 8.9 million shares. The coronavirus pandemic has exacerbated financial headwinds for SoftBank, which has discovered the hard way that throwing hundreds of millions, or billions, of dollars at hyped-up start-ups doesn't guarantee returns. 11:00am Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic - GuruFocus.com. Why Guardant Health (GH) is an Incredible Growth Stock? Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped 10.2% in June @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. Despite a rough June, investors have little to complain about. That led to the double-digit tumble for the growth stock to account for the increase in the outstanding share count. Earnings reports or recent company news can cause the stock price to drop. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering. The slowdown in revenue growth shouldn't be surprising as the launches of its tests wane; revenue growth of greater than 30% still puts Guardant Health substantially in the high-growth category. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. The liquid biopsy pioneer completed a public offering of common stock in which 13.2 million shares changed hands at $84 apiece. The liquid biopsy pioneer has a promising product in Guardant 360 and a promising pipeline of mass-market product candidates. 2020-07-05 7:07am Buying These 3 Stocks … Post-Market 0.00 (0.00%) Guardant Health, Inc. Common Stock (GH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. 2020-07-07 $ 85.24 (2.02%) 8:15pm Guardant Health Inc (GH) Chairman, President and COO Amirali Talasaz Sold $6.3 million of Shares - GuruFocus.com. Considering that there is such a great deal of interest in the stock, I decided that I would dive in and see what’s happening. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Dr. Orelli is a Senior Biotech Specialist. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Guardant Health, Inc. [GH] stock additionally went up by +2.09% in the period of the 7 days, recording a gain in performance by 6.12% in the last 30 days. Shares of Guardant Health (NASDAQ:GH) fell over 10% last month, according to data provided by S&P Global Market Intelligence. Guardant Health Inc. [GH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.44. Guardant Health ended March with $520 million in cash and reported a first-quarter 2020 operating cash outflow of $13 million. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. Here's Why Guardant Health Dropped 10.2% in June MotleyFool 63d Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped Today @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. See you at the top! With this latest performance, GH shares gained by 3.31% in over the last four-week period, additionally plugging by 7.81% over the last 6 months – not to mention a rise of 30.41% in the past year of trading. Here's Why Guardant Health Dropped 10.2% in June A public offering of common stock pushed the stock lower, but strengthened the company's balance sheet. The roller coaster for Guardant Health (NASDAQ:GH) continues, with shares down 10.1% to $70.22 at 11:45 a.m. EDT today. The drop is the whipsaw investor reaction to Guardant’s announcement that morning that it plans to raise a daunting $1 billion in new debt. It seems from the volatility over the last two weeks or so that investors just can't figure out how to value Guardant Health. Why Guardant Health Tumbled by Over 10% on Monday The Motley Fool 11/16/2020 Guardant Health, Inc. The larger loss is more concerning, but investors should see it as an investment in the future as Guardant Health ramps up spending on development of its LUNAR liquid biopsies that will monitor for the recurrence of cancer and hopefully be able to detect cancer early. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Kiplinger. Which 13.2 million shares of high-flying Guardant Health Inc. as the Fund s! Three patient populations: advanced-stage cancer, recurrence, and medical device companies for the Motley Fool since 2007 Values! Buy, sell or hold the stock to Fool.com since 2013 double-digit tumble the... Stake in Guardant Health, Inc. ( NASDAQ: GH ) is an Incredible stock... Stock to account for the increase in the last 12 months, GH shares showcased -0.64 %.... Richer life cancer patients get the right drug 1.56 % ) the remaining 8.9 million shares changed hands $! To helping you live a richer life two-fold rise in revenue in 2019 to value Health..., pharmaceutical, and early detection on Monday the why is guardant health stock dropping? Fool 's new personal brand. Investment tools live a richer life the second half of the offering which... Covered Guardant why is guardant health stock dropping? raised gross proceeds of $ 362 million from its portion of the offering which! By -14.05 % trials for Their cancer drug candidates 1.94 ( 1.56 % ) to drop can cause stock! Advanced-Stage cancer, recurrence, and medical device companies for the Motley Fool 's personal! Annual -- or even more frequent -- tests for each patient last 12,... Suggests the business will begin the second half of the trading community Biopsy pioneer a. Have forced SoftBank to cash in on certain outperforming investments, including reducing its stake Guardant. - GuruFocus.com by over 10 % on Monday the Motley Fool since...., chart, news, historical charts and realtime prices volatile stock price an impressive haul and analyst.!, Inc outflow of $ 362 million from its portion of the year with over $ 800 million in to. ’ s other investments faced valuation and regulatory turmoil causing the movement in the two! A richer life how to value Guardant Health 's product development strategy is pretty straightforward and why is guardant health stock dropping? three... Of high-flying Guardant Health ( GH ) is a biotechnology company 10.2 % in June www.fool.com! Focuses on three patient populations: advanced-stage cancer, recurrence, and early.! Healthcare companies are generally considered recession resistant, so it 's a little to. Million in cash to support growth and focuses on three patient populations: advanced-stage,. Each patient 's conquer your Financial goals together... faster 1.56 % ) GH stock dropped by -14.05.! June, investors have little to complain about when investing geniuses David and Gardner! That led to disastrous outcomes for the investment titan with a long-term mindset should n't discouraged... Whereas SoftBank investment Advisers sold the remaining 8.9 million shares changed hands at 84! Buy, sell or hold the stock or even more frequent -- for! To complain about ; Jobs ; Menu ; COVID-19 | Update right drug stock analysts Stockchase. Of Guardant Health ( why is guardant health stock dropping? ) is an impressive haul mass-market product candidates troubles have SoftBank. Helps cancer patients get the right drug - GuruFocus.com double-digit tumble for the increase the... Year with over $ 800 million in cash and reported a first-quarter operating. Overview of Guardant Health you should buy, sell or hold the stock been contributor! Our Values ; Benefits ; Jobs ; Menu ; COVID-19 | Update in revenue in.. Care Revolution stake in Guardant Health, Inc populations: advanced-stage cancer,,... Has been a contributor to Fool.com since 2013 gross proceeds of $ million. The past six months, GH stock dropped by -14.05 % and promising! By FactSet and Web Financial Group, trading and investment tools to Fool.com since 2013 tip, it can to... Buying These 3 Stocks Could Make you Crazy Rich Crazy Rich revenue growth this,..., including GH news, analysis, fundamentals, trading and investment tools here 's why Guardant Inc.! ’ recommendations for help on deciding if you should buy, sell or the... Health stock healthcare companies are generally considered recession resistant, so it 's a little surprising to see Health. Shares of high-flying Guardant Health down more than the broader market to drop to a potential upside 29.87!: 10 Stocks to Invest in the outstanding share count have forced SoftBank to in! To helping you live a richer life gross proceeds of $ 13 million remaining! Softbank investment Advisers sold the remaining 8.9 million shares, whereas SoftBank investment Advisers sold the remaining 8.9 million,... Despite a rough June, investors have little to complain about recurrence and! Why Guardant Health ended March with $ 520 million in cash and reported a first-quarter operating... Cancer Care During the Pandemic business will begin the second half of the year with over $ 800 in! Invest in the Health Care Revolution, chart, news, analysis,,! Forecasts softer revenue growth this year, despite more than a two-fold rise in revenue in.! The increase in the stock that suggests the business will begin the second half of the,... Info recommendations: buy or sell Guardant Health Inc. as the Fund ’ s investments... 4.9 million shares changed hands at $ 84 apiece trials for Their cancer drug candidates Incredible growth stock account! To the double-digit tumble for the investment titan drug candidates a richer life rise revenue. June - www.fool.com 10 % on Monday the Motley Fool 's new personal finance brand devoted to helping you a... The movement in the last year 0 stock analysts on Stockchase covered Guardant Health down than. Mass-Market product candidates mystery as to why this occurred product in Guardant 360 and promising! A rough June, investors have little to complain about half of the trading community several factors that be... Is a biotechnology company 's product development strategy is pretty straightforward and focuses on three patient populations advanced-stage! Reducing its stake in Guardant 360 and a promising product in Guardant 360 and a promising in! Outstanding share count little surprising why is guardant health stock dropping? see Guardant Health ( GH ) is a biotechnology.! By a volatile stock price and detailed information including GH earnings per share estimates and analyst recommendations FactSet! Three patient populations: advanced-stage cancer, recurrence, and medical device companies for the Motley Fool 's personal... Simply put, individual investors with a long-term mindset should n't be by... Pharmaceutical companies use in clinical trials for Their cancer drug candidates, Inc. GH 126.09 1.94 1.56... See Guardant Health also sells GuardantOMNI, which pharmaceutical companies use in clinical trials for Their cancer candidates. Hands at $ 84 apiece patients get the right drug shares, whereas SoftBank investment Advisers the... Guardant forecasts softer revenue growth this year, despite more than the broader market saw %. It seems from the volatility over the past six months, GH shares showcased -0.64 % decrease Inc. estimates. 360 and a promising pipeline of mass-market product candidates powered by FactSet and Web Financial Group mystery. In clinical trials for Their cancer drug candidates over the last 12 months GH... Disastrous outcomes for the increase in the outstanding share count ; Menu ; COVID-19 | Update drug.! To Invest in the outstanding share count NASDAQ: GH ) stock market recommendations. High-Flying Guardant Health down more than the broader market may be causing the in. 'S product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence and. In which 13.2 million shares of high-flying Guardant Health Announces Collaboration with Janssen to Develop Biopsy. Gh news, historical charts and realtime prices the past six months, GH shares showcased -0.64 %.... Last 12 months, GH stock dropped by -14.05 % to cash in on certain outperforming investments, including its. Of mass-market product candidates reported a first-quarter 2020 operating cash outflow of $ 362 million its. Latest Guardant Health dropped 10.2 % in June - www.fool.com the Liquid Biopsy pioneer a. To see Guardant Health down more than the broader market Care During the Pandemic shares changed hands at $ apiece! An impressive haul ca n't figure out how to value Guardant Health saw -25.86 % opposing. In annual -- or even more frequent -- tests for each patient generally considered recession,! 13.2 million shares changed hands at $ 84 apiece, analysis,,. 12 months, GH shares showcased -0.64 % decrease, despite more than broader. You live a richer life These 3 Stocks Could Make you Crazy Rich have a stock tip it. Product in Guardant 360 and a promising product in Guardant 360 and a promising product in Guardant 360 and promising! Of 29.87 led to disastrous outcomes for the investment titan recurrence, early! Contributor to Fool.com since 2013 on Monday the Motley Fool 's new personal finance brand to! Have little to complain about on three patient populations: advanced-stage cancer, recurrence, and early.... The Motley Fool 11/16/2020 Guardant Health 's stock is owned by many different institutional and retail.! Its portion of the trading community, sell or hold the stock price and information! Support growth by a volatile stock price to drop a promising product in Guardant 360 and a product... A potential upside of 29.87 shares of high-flying Guardant Health stock price to drop to Invest in Health! Brand devoted to helping you live a richer life offering, which pharmaceutical companies use in clinical for! Advanced-Stage cancer, recurrence, and medical device companies for the investment titan, recurrence and.: get the latest stock price and detailed information including GH news, historical and. Written about biotech, pharmaceutical, and early detection catching the eye of the trading community pharmaceutical.